Related Experiment Video
Updated: Nov 10, 2025

Generation of Organ-conditioned Media and Applications for Studying Organ-specific Influences on Breast Cancer Metastatic Behavior
Published on: June 13, 2016
Understanding the function of the tumor microenvironment, and compounds from marine organisms for breast cancer
Rama Rao Malla1, Batoul Farran2, Ganji Purnachandra Nagaraju3
1Department of Biochemistry and Bioinformatics, GITAM (Deemed to be University), Visakhapatnam 530045, AP, India.
Abstract:
The pathology and physiology of breast cancer (BC), including metastasis, and drug resistance, is driven by multiple signaling pathways in the tumor microenvironment (TME), which hamper antitumor immunity. Recently, long non-coding RNAs have been reported to mediate pathophysiological develop-ments such as metastasis as well as immune suppression within the TME. Given the complex biology of BC, novel personalized therapeutic strategies that address its diverse pathophysiologies are needed to improve clinical outcomes. In this review, we describe the advances in the biology of breast neoplasia, including cellular and molecular biology, heterogeneity, and TME. We review the role of novel molecules such as long non-coding RNAs in the pathophysiology of BC. Finally, we provide an up-to-date overview of anticancer compounds extracted from marine microorganisms, crustaceans, and fishes and their synergistic effects in combination with other anticancer drugs. Marine compounds are a new discipline of research in BC and offer a wide range of anti-cancer effects that could be harnessed to target the various pathways involved in BC development, thus assisting current therapeutic regimens.
Insights
Breast cancer (BC) progression involves complex signaling pathways and immune suppression. Marine compounds offer novel therapeutic strategies targeting these pathways for improved BC treatment.
Area of Science:
- Oncology
- Molecular Biology
- Marine Biotechnology
Background:
- Breast cancer (BC) pathology, including metastasis and drug resistance, is driven by tumor microenvironment (TME) signaling pathways that suppress antitumor immunity.
- Long non-coding RNAs (lncRNAs) are emerging as key mediators of BC pathophysiological developments and immune suppression within the TME.
- The complex biology of BC necessitates novel, personalized therapeutic strategies to improve patient outcomes.
Purpose of the Study:
- To review advances in breast neoplasia biology, encompassing cellular and molecular aspects, heterogeneity, and the TME.
- To examine the role of novel molecules, specifically lncRNAs, in BC pathophysiology.
- To provide an overview of anticancer compounds from marine sources and their synergistic potential in BC therapy.
Main Methods:
- Literature review of current research on breast cancer biology, TME, lncRNAs, and marine-derived anticancer compounds.
- Analysis of signaling pathways involved in BC progression, metastasis, and immune evasion.
- Evaluation of the potential synergistic effects of marine compounds with existing anticancer drugs.
Main Results:
- BC progression is significantly influenced by TME signaling and lncRNA activity, impacting antitumor immunity.
- Marine microorganisms, crustaceans, and fishes are sources of novel compounds with diverse anticancer effects.
- Marine compounds show promise for synergistic effects when combined with conventional therapies, targeting multiple BC pathways.
Conclusions:
- Understanding BC's complex molecular and cellular biology, including the TME and lncRNAs, is crucial for developing effective treatments.
- Marine-derived compounds represent a promising new avenue for BC therapy, offering unique mechanisms to target cancer progression.
- Harnessing marine compounds could lead to innovative, synergistic therapeutic regimens to improve clinical outcomes in breast cancer patients.
Related Concept Videos
The Tumor Microenvironment
Targeted Cancer Therapies
There are several types of targeted therapies against...
Drugs that Stabilize Microtubules
Tumor Immunotherapy
Drugs that Destabilize Microtubules
Metastasis
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...

